Exact Mass: 348.0470988

Exact Mass Matches: 348.0470988

Found 254 metabolites which its exact mass value is equals to given mass value 348.0470988, within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error 0.01 dalton.

Inosine 5'-monophosphate (IMP)

{[(2R,3S,4R,5R)-3,4-dihydroxy-5-(6-oxo-6,9-dihydro-1H-purin-9-yl)oxolan-2-yl]methoxy}phosphonic acid

C10H13N4O8P (348.0470988)


Inosinic acid, also known as inosine monophosphate, IMP, 5-inosinate or 5-IMP, belongs to the class of organic compounds known as purine ribonucleoside monophosphates. These are nucleotides consisting of a purine base linked to a ribose to which one monophosphate group is attached. IMP is also classified as a nucleotide (a nucleoside monophosphate). Inosinic acid exists in all living species, ranging from bacteria to plants to humans. IMP is widely used as a flavor enhancer. In the food industry it is known as E number reference E630. Inosinic acid can be converted into various salts including disodium inosinate (E631), dipotassium inosinate (E632), and calcium inosinate (E633). These three inosinate compounds are used as flavor enhancers for the basic taste umami. These inosinate salts are mostly used in soups, sauces, and seasonings for the intensification and balance of the flavor of meat. Inosinic acid is typically obtained from chicken byproducts or other meat industry waste. Inosinic acid or IMP is important in metabolism. It is the ribonucleotide of hypoxanthine and the first nucleotide formed during the synthesis of purine nucleotides. It can also be formed by the deamination of adenosine monophosphate by AMP deaminase. GMP is formed by the inosinate oxidation to xanthylate (XMP). Within humans, inosinic acid participates in a number of enzymatic reactions. In particular, inosinic acid can be converted into phosphoribosyl formamidocarboxamide; which is catalyzed by the bifunctional purine biosynthesis protein. In addition, inosinic acid can be converted into xanthylic acid; which is catalyzed by the enzyme inosine-5-monophosphate dehydrogenase 1. Origin: Microbe; Formula(Parent): C10H13N4O8P; Bottle Name:Inosine-5-monophosphate; PRIME Parent Name:Inosine-5-monophosphate; PRIME in-house No.:0258, Purines A purine nucleotide which has hypoxanthine as the base and one phosphate group esterified to the sugar moiety. COVID info from clinicaltrial, clinicaltrials, clinical trial, clinical trials, COVID-19 Disease Map Acquisition and generation of the data is financially supported in part by CREST/JST. relative retention time with respect to 9-anthracene Carboxylic Acid is 0.056 relative retention time with respect to 9-anthracene Carboxylic Acid is 0.057 Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS Inosinic acid is an endogenous metabolite.

   

2-(alpha-D-Mannosyl)-3-phosphoglycerate

2-(α-D-Mannosyl)-3-phosphoglycerate

C9H17O12P (348.0457612)


   

2-O-(6-Phospho-alpha-mannosyl)-D-glycerate

(2R)-3-hydroxy-2-{[(2R,3S,4S,5S,6R)-3,4,5-trihydroxy-6-[(phosphonooxy)methyl]oxan-2-yl]oxy}propanoic acid

C9H17O12P (348.0457612)


2-O-(6-Phospho-alpha-mannosyl)-D-glycerate is an alpha-D-mannosylglycerate (MG) that is an intermediate in 2-O-alpha-mannosyl-D-glycerate degradation. It can be generated from 2-O-alpha-mannosyl-D-glycerate via the enzyme 2-O-alpha-mannosyl-D-glycerate transporting phosphotransferase system (mngA). 2-O-Alpha-mannosyl-D-glycerate is a natural extremolyte identified in microorganisms growing under extremely high temperatures up to 100 oC, and had been shown to protect proteins against various stress conditions such as heat, freezing, thawing, and drying. MG that is naturally occurring hyperthermophilic osmolytes, could be potential drug candidates or lead compounds against alpha,beta aggregation associated with Alzheimers disease(PMID: 18304694). In most organisms MG is produced from guanosine pyrophosphate mannose (GDP-alpha-D-mannose) via mannosyl-3-phosphoglycerate in two steps, catalyzed by the enzymes mannosyl-3-phosphoglycerate synthase and mannosyl-3-phosphoglycerate phosphatase. [HMDB] 2-O-(6-Phospho-alpha-mannosyl)-D-glycerate is an alpha-D-mannosylglycerate (MG) that is an intermediate in 2-O-alpha-mannosyl-D-glycerate degradation. It can be generated from 2-O-alpha-mannosyl-D-glycerate via the enzyme 2-O-alpha-mannosyl-D-glycerate transporting phosphotransferase system (mngA). 2-O-Alpha-mannosyl-D-glycerate is a natural extremolyte identified in microorganisms growing under extremely high temperatures up to 100 oC, and had been shown to protect proteins against various stress conditions such as heat, freezing, thawing, and drying. MG that is naturally occurring hyperthermophilic osmolytes, could be potential drug candidates or lead compounds against alpha,beta aggregation associated with Alzheimers disease(PMID: 18304694). In most organisms MG is produced from guanosine pyrophosphate mannose (GDP-alpha-D-mannose) via mannosyl-3-phosphoglycerate in two steps, catalyzed by the enzymes mannosyl-3-phosphoglycerate synthase and mannosyl-3-phosphoglycerate phosphatase.

   

Doxefazepam

Doxefazepam

C17H14ClFN2O3 (348.0676936)


N - Nervous system > N05 - Psycholeptics > N05C - Hypnotics and sedatives > N05CD - Benzodiazepine derivatives C78272 - Agent Affecting Nervous System > C29756 - Sedative and Hypnotic > C1012 - Benzodiazepine C78272 - Agent Affecting Nervous System > C28197 - Antianxiety Agent

   

1,2,3,4-Tetrahydro-alpha,7-dihydroxy-beta-(hydroxymethyl)-9-methoxy-3,4-dioxocyclopenta[c][1]benzopyran-6-propanal

1,2,3,4-Tetrahydro-alpha,7-dihydroxy-beta-(hydroxymethyl)-9-methoxy-3,4-dioxocyclopenta[c][1]benzopyran-6-propanal

C17H16O8 (348.0845136)


   

alpha-(1,2-Dihydroxyethyl)-1,2,3,4-tetrahydro-7-hydroxy-9-methoxy-3,4-dioxocyclopenta[c][1]benzopyran-6-acetaldehyde

alpha-(1,2-Dihydroxyethyl)-1,2,3,4-tetrahydro-7-hydroxy-9-methoxy-3,4-dioxocyclopenta[c][1]benzopyran-6-acetaldehyde

C17H16O8 (348.0845136)


alpha-(1,2-Dihydroxyethyl)-1,2,3,4-tetrahydro-7-hydroxy-9-methoxy-3,4-dioxocyclopenta[c][1]benzopyran-6-acetaldehyde is considered to be slightly soluble (in water) and acidic

   

2-keto-3-deoxy-D-glycero-D-galacto-nononate 9-phosphate

2-Keto-3-deoxy-D-glycero-D-galacto-nononate 9-phosphate; 3-Deoxy-D-glycero-D-galacto-non-2-ulosonate 9-phosphate; KDN 9-phosphate

C9H17O12P (348.0457612)


   

Verinurad

Verinurad

C20H16N2O2S (348.0932436)


D018501 - Antirheumatic Agents > D006074 - Gout Suppressants C26170 - Protective Agent > C921 - Uricosuric Agent

   

(2R)-2-(alpha-D-glucopyranosyloxy)-3-(phosphonooxy)propanoic acid

(2R)-2-(alpha-D-glucopyranosyloxy)-3-(phosphonooxy)propanoic acid

C9H17O12P (348.0457612)


   

Succisulfone

4-[[4-[(4-aminophenyl)sulphonyl]phenyl]amino]-4-oxobutyric acid

C16H16N2O5S (348.0779886)


C254 - Anti-Infective Agent > C29739 - Sulfonamide Anti-Infective Agent

   

5,7,8-trihydroxy-2-(3-hydroxy-4-methoxyphenyl)-3-methoxy-3,4-dihydro-2H-1-benzopyran-4-one

5,7,8-trihydroxy-2-(3-hydroxy-4-methoxyphenyl)-3-methoxy-3,4-dihydro-2H-1-benzopyran-4-one

C17H16O8 (348.0845136)


   
   

Inosine 2'-phosphate

{[(2R,3R,4R,5R)-4-hydroxy-5-(hydroxymethyl)-2-(6-oxo-6,9-dihydro-3H-purin-9-yl)oxolan-3-yl]oxy}phosphonic acid

C10H13N4O8P (348.0470988)


Inosine 2-phosphate is an inosine nucleotide containing a pyrophosphate group esterified to C2 of the sugar moiety. Inosine 2-phosphate is a product of 2,3-cyclic-nucleotide 3-phosphodiesterase (EC 3.1.4.37). This enzyme (also called CNP) catalyzes the chemical reaction: nucleoside 2,3-cyclic phosphate + H2O <-> nucleoside 2-phosphate. 2,3-cyclic nucleotide 3-phosphodiesterase is a myelin-associated enzyme that makes up 4\\% of total CNS myelin protein, and is thought to undergo significant age-associated changes. The absence of CNP causes axonal swelling and neuronal degeneration. [HMDB] Inosine 2-phosphate is an inosine nucleotide containing a pyrophosphate group esterified to C2 of the sugar moiety. Inosine 2-phosphate is a product of 2,3-cyclic-nucleotide 3-phosphodiesterase (EC 3.1.4.37). This enzyme (also called CNP) catalyzes the chemical reaction: nucleoside 2,3-cyclic phosphate + H2O <-> nucleoside 2-phosphate. 2,3-cyclic nucleotide 3-phosphodiesterase is a myelin-associated enzyme that makes up 4\\% of total CNS myelin protein, and is thought to undergo significant age-associated changes. The absence of CNP causes axonal swelling and neuronal degeneration.

   

Formononetin 7-sulfate

[3-(4-Methoxyphenyl)-4-oxo-4H-chromen-7-yl]oxidanesulphonic acid

C16H12O7S (348.0303722)


   

Glucose-6-phosphate lactate

({3,4,5,6-tetrahydroxy-6-[(2-hydroxypropanoyl)oxy]oxan-2-yl}methoxy)phosphonic acid

C9H17O12P (348.0457612)


   

[(2R,5R)-3,4-Dihydroxy-5-(6-oxo-1H-purin-9-yl)oxolan-2-yl]methyl dihydrogen phosphate

[(2R,5R)-3,4-Dihydroxy-5-(6-oxo-1H-purin-9-yl)oxolan-2-yl]methyl dihydrogen phosphate

C10H13N4O8P (348.0470988)


Flavour enhancer

   

Cloxazolam, (R)-

13-chloro-2-(2-chlorophenyl)-3-oxa-6,9-diazatricyclo[8.4.0.0²,⁶]tetradeca-1(10),11,13-trien-8-one

C17H14Cl2N2O2 (348.0432284)


N - Nervous system > N05 - Psycholeptics > N05B - Anxiolytics > N05BA - Benzodiazepine derivatives C78272 - Agent Affecting Nervous System > C28197 - Antianxiety Agent

   

Verinurad

2-{[3-(4-cyanonaphthalen-1-yl)pyridin-4-yl]sulphanyl}-2-methylpropanoic acid

C20H16N2O2S (348.0932436)


D018501 - Antirheumatic Agents > D006074 - Gout Suppressants C26170 - Protective Agent > C921 - Uricosuric Agent

   

8-Demethylthymonin

5,6,8-trihydroxy-2-(4-hydroxy-3-methoxyphenyl)-7-methoxy-3,4-dihydro-2H-1-benzopyran-4-one

C17H16O8 (348.0845136)


8-demethylthymonin is a member of the class of compounds known as 7-o-methylated flavonoids. 7-o-methylated flavonoids are flavonoids with methoxy groups attached to the C7 atom of the flavonoid backbone. 8-demethylthymonin is practically insoluble (in water) and a very weakly acidic compound (based on its pKa). 8-demethylthymonin can be found in common thyme, which makes 8-demethylthymonin a potential biomarker for the consumption of this food product.

   
   
   
   

Taiwanin C

Taiwanin C

C20H12O6 (348.06338519999997)


A furonaphthodioxole that is furo[3,4:6,7]naphtho[2,3-d][1,3]dioxol-6(8H)-one substituted by a 1,3-benzodioxol-5-yl group at position 5. It is a naturally occurring lignan extracted from Taiwania cryptomerioides and found to be a potential inhibitor of COX2 expression.

   

Dihydrogossypetin 7,8-dimethyl ether

3,5,3,4-Tetrahydroxy-7,8-dimethoxyflavanone

C17H16O8 (348.0845136)


   

Dihydrosyringetin

3,5,7,4-Tetrahydroxy-3,5-dimethoxyflavanone

C17H16O8 (348.0845136)


   
   
   
   
   
   

Helioxanthin

Helioxanthin

C20H12O6 (348.06338519999997)


A furonaphthodioxole that is furo[3,4:6,7]naphtho[1,2-d][1,3]dioxol-7(9H)-one substituted by a 1,3-benzodioxol-5-yl group at posiiton 10. It is a inhibitor of HBV, HCV and HSV-1 viruses.

   

3,5,7,3-Tetrahydroxy-8,4-dimethoxyflavanone

3,5,7,3-Tetrahydroxy-8,4-dimethoxyflavanone

C17H16O8 (348.0845136)


   
   

3,5,7,3,4,5-Hexahydroxy-6,8-dimethylflavanone

3,5,7,3,4,5-Hexahydroxy-6,8-dimethylflavanone

C17H16O8 (348.0845136)


   

2H-Naphtho[2,3-b]pyran-6,9-dione,3,4-dihydro-4,5,10-trihydroxy-8-methoxy-2-(2-oxopropyl)-,(2R,4S)-

2H-Naphtho[2,3-b]pyran-6,9-dione,3,4-dihydro-4,5,10-trihydroxy-8-methoxy-2-(2-oxopropyl)-,(2R,4S)-

C17H16O8 (348.0845136)


   

1,7-Dihydroxy-2,3,4,5-tetramethoxy-xanthone

1,7-Dihydroxy-2,3,4,5-tetramethoxy-xanthone

C17H16O8 (348.0845136)


   

2-(1,1-Dimethyl-2-propenyl)-3-[2-(methylformylamino)ethyl]-6-bromo-1H-indole

2-(1,1-Dimethyl-2-propenyl)-3-[2-(methylformylamino)ethyl]-6-bromo-1H-indole

C17H21BrN2O (348.0837156)


   
   
   

Dryopteric acid

(2R) -2alpha- (3,4-Dihydroxyphenyl) -3alpha,5,7-trihydroxy-3,4-dihydro-2H-1-benzopyran-4beta-acetic acid

C17H16O8 (348.0845136)


   
   
   
   

2-[(4-Chlorophenyl)sulfonyl]-3-[(4,6-dimethylpyrimidin-2-yl)amino]acrylonitrile

2-[(4-Chlorophenyl)sulfonyl]-3-[(4,6-dimethylpyrimidin-2-yl)amino]acrylonitrile

C15H13ClN4O2S (348.04477080000004)


   

N-[4-(2,3-dihydro-1,4-benzodioxin-6-ylsulfamoyl)phenyl]acetamide

N-[4-(2,3-dihydro-1,4-benzodioxin-6-ylsulfamoyl)phenyl]acetamide

C16H16N2O5S (348.0779886)


   

O1-[4-(tert-Butyl)benzoyl]-2-(2-thienylthio)ethanehydroximamide

O1-[4-(tert-Butyl)benzoyl]-2-(2-thienylthio)ethanehydroximamide

C17H20N2O2S2 (348.096614)


   
   

3(2-Chlorophenyl)-7-hydroxy-4-phenylcoumarin

3(2-Chlorophenyl)-7-hydroxy-4-phenylcoumarin

C21H13ClO3 (348.0553178)


relative retention time with respect to 9-anthracene Carboxylic Acid is 1.266 relative retention time with respect to 9-anthracene Carboxylic Acid is 1.265 relative retention time with respect to 9-anthracene Carboxylic Acid is 1.268

   

3-Benzyloxy-2-phenyl-benzo[b]thiophen-1,1-dioxid|3-benzyloxy-2-phenyl-benzo[b]thiophene 1,1-dioxide

3-Benzyloxy-2-phenyl-benzo[b]thiophen-1,1-dioxid|3-benzyloxy-2-phenyl-benzo[b]thiophene 1,1-dioxide

C21H16O3S (348.0820106)


   

18-Bromo-(17Z)-octadeca-17-ene-5,7,15-triynoic acid

18-Bromo-(17Z)-octadeca-17-ene-5,7,15-triynoic acid

C18H21BrO2 (348.0724826)


   
   
   
   
   
   
   

4-Bromophenylhydrazone-D-Glucose

4-Bromophenylhydrazone-D-Glucose

C12H17BrN2O5 (348.0320772)


   
   

Isobutyric acid (2,2:5,2-terthiophen-5-yl)methyl ester

Isobutyric acid (2,2:5,2-terthiophen-5-yl)methyl ester

C17H16O2S3 (348.0312396)


   

Me ester-Diploschistesic acid

Me ester-Diploschistesic acid

C17H16O8 (348.0845136)


   

(3,4,5-trihydroxy-6-methoxyoxan-2-yl)methyl 4-methylbenzenesulfonate

(3,4,5-trihydroxy-6-methoxyoxan-2-yl)methyl 4-methylbenzenesulfonate

C14H20O8S (348.08788400000003)


   

1,3-Dihydroxy-2,4,5,7-tetramethoxy-9H-xanthene-9-one

1,3-Dihydroxy-2,4,5,7-tetramethoxy-9H-xanthene-9-one

C17H16O8 (348.0845136)


   
   
   

5-acetoxymethylen-2-(4-acetoxy-but-3-inyl)-dithiophene|5-acetoxymethylen-2-<4-acetoxy-but-3-inyl>-dithiophene|Di-Ac-4-[5-(Hydroxymethyl)-[2,2-bithiophen-5-yl]]-3-butyn-1-ol

5-acetoxymethylen-2-(4-acetoxy-but-3-inyl)-dithiophene|5-acetoxymethylen-2-<4-acetoxy-but-3-inyl>-dithiophene|Di-Ac-4-[5-(Hydroxymethyl)-[2,2-bithiophen-5-yl]]-3-butyn-1-ol

C17H16O4S2 (348.0489976)


   

4-ethyl 4-methyl 2,3,5,6-tetrahydroxy[1,1-biphenyl]-4,4-dicarboxylate

4-ethyl 4-methyl 2,3,5,6-tetrahydroxy[1,1-biphenyl]-4,4-dicarboxylate

C17H16O8 (348.0845136)


   
   

Di-Ac-4-[5-Methyl-[2,2-bithiophen]-5-yl]-3-butyne-1,2-diol

Di-Ac-4-[5-Methyl-[2,2-bithiophen]-5-yl]-3-butyne-1,2-diol

C17H16O4S2 (348.0489976)


   
   
   
   

crassifogenin C

crassifogenin C

C17H16O8 (348.0845136)


A norlignan that is 3-deoxypentodialdo-5,4-oxirose substituted at positions 1 and 4 by 3,4-dihydroxyphenyl groups. It is isolated from the rhizomes of Curculigo crassifolia and exhibits strong radical scavenging activity.

   

(1R*,5S*,9S*,13R*,14R*)-11,14,16-trihydroxy-10,17-dimethyl-3,7-dioxapentacyclo[11.4.0.01,5.05,9.09,14]heptadeca-10,16-diene-4,12,15-trione|epicolactone

(1R*,5S*,9S*,13R*,14R*)-11,14,16-trihydroxy-10,17-dimethyl-3,7-dioxapentacyclo[11.4.0.01,5.05,9.09,14]heptadeca-10,16-diene-4,12,15-trione|epicolactone

C17H16O8 (348.0845136)


   

Desmethyl Jaboticabin Ethyl Carboxylate

Desmethyl Jaboticabin Ethyl Carboxylate

C17H16O8 (348.0845136)


   

(5R,6R)-6-{2-[(1E)-1-(5-chloro-1H-pyrrol-2-yl)prop-1-en-2-yl]-1,3-oxazol-4-yl}-4-methoxy-5-methyl-5,6-dihydro-2H-pyran-2-one|pyrronazol B

(5R,6R)-6-{2-[(1E)-1-(5-chloro-1H-pyrrol-2-yl)prop-1-en-2-yl]-1,3-oxazol-4-yl}-4-methoxy-5-methyl-5,6-dihydro-2H-pyran-2-one|pyrronazol B

C17H17ClN2O4 (348.0876792)


   

5,7,2,4-tetrahydroxy-6,5-dimethoxyflavone

5,7,2,4-tetrahydroxy-6,5-dimethoxyflavone

C17H16O8 (348.0845136)


   

methyl (R)-3-[2-(3,4-dihydroxybenzoyl)-4,5-dihydroxyphenyl]-2-hydroxypropanoate

methyl (R)-3-[2-(3,4-dihydroxybenzoyl)-4,5-dihydroxyphenyl]-2-hydroxypropanoate

C17H16O8 (348.0845136)


   
   

L-Aspartyl-L-N2-hydroxyaspartyl-D-cycloserine

L-Aspartyl-L-N2-hydroxyaspartyl-D-cycloserine

C11H16N4O9 (348.0917246)


   

(8beta)-10-bromo-3-chloro-2,7-epoxychamigr-9-en-8-ol|rel-(2R,3S,5aR,9S,9aR)-7-bromo-3-chloro-2,3,4,5,9,9a-hexahydro-3,6,6,9a-tetramethyl-6H-2,5a-methano-1-benzoxepin-9-ol

(8beta)-10-bromo-3-chloro-2,7-epoxychamigr-9-en-8-ol|rel-(2R,3S,5aR,9S,9aR)-7-bromo-3-chloro-2,3,4,5,9,9a-hexahydro-3,6,6,9a-tetramethyl-6H-2,5a-methano-1-benzoxepin-9-ol

C15H22BrClO2 (348.0491602)


   

Chloroisosulochrin dehydrate

Chloroisosulochrin dehydrate

C17H13ClO6 (348.0400628)


   

1-naphthoic acid glucuronide

1-naphthoic acid glucuronide

C17H16O8 (348.0845136)


   

5-methyl-[5-(3-hydroxy-4-isovaleroxy-1-butynyl)]-2,2-bithiophene

5-methyl-[5-(3-hydroxy-4-isovaleroxy-1-butynyl)]-2,2-bithiophene

C18H20O3S2 (348.08538100000004)


   
   

3,8-Dihydroxy-1,2,4,6-tetramethoxyxanthen-9-one

3,8-Dihydroxy-1,2,4,6-tetramethoxyxanthen-9-one

C17H16O8 (348.0845136)


   
   

(7E,13E,17E)-form-18-Bromo-7,13,17-octadecatriene-5,15-diynoic acid

(7E,13E,17E)-form-18-Bromo-7,13,17-octadecatriene-5,15-diynoic acid

C18H21BrO2 (348.0724826)


   

1-Hydroxy-3-methyl-8,10-dimethoxy-9-chlorodibenz[b,e]oxepin-6,11-dione

1-Hydroxy-3-methyl-8,10-dimethoxy-9-chlorodibenz[b,e]oxepin-6,11-dione

C17H13ClO6 (348.0400628)


   
   

7-dechlorovicanicin|pannarin

7-dechlorovicanicin|pannarin

C18H17ClO5 (348.0764462)


   
   
   

Chaetocyclinone A

Chaetocyclinone A

C17H16O8 (348.0845136)


An organic heterotricyclic compound that is 1H,10H-pyrano[4,3-b]chromene substituted by methoxy, methyl, hydroxy, methoxy, methoxycarbonyl, and oxo groups at positions 1, 3, 6, 7, 9 and 10, respectively. It is produced by cultures of Chaetomium sp. Goe 100/2, which was isolated from marine algae.

   

7-Methoxy-2-phenyl-3-sulfooxy-chromen-4-on|7-methoxy-2-phenyl-3-sulfooxy-chromen-4-one|rhamnocitrin 3-sulphate

7-Methoxy-2-phenyl-3-sulfooxy-chromen-4-on|7-methoxy-2-phenyl-3-sulfooxy-chromen-4-one|rhamnocitrin 3-sulphate

C16H12O7S (348.0303722)


   
   

Dehydro-L-(+)-ascorbic acid dimer

Dehydro-L-(+)-ascorbic acid dimer

C12H12O12 (348.03287520000003)


   

Asterric acid_120092

Asterric acid_120092

C17H16O8 (348.0845136)


   

Hydroxysulochrin_120241

Hydroxysulochrin_120241

C17H16O8 (348.0845136)


   

Inosine 5-monophosphate

Inosine 5-monophosphate

C10H13N4O8P (348.0470988)


   

5-Inosinic Acid

Inosine-5-monophosphate

C10H13N4O8P (348.0470988)


Inosinic acid is an endogenous metabolite.

   

2-hydroxy-6-(2-hydroxy-4-methoxy-6-methoxycarbonylphenoxy)-4-methylbenzoic acid

NCGC00384947-01!2-hydroxy-6-(2-hydroxy-4-methoxy-6-methoxycarbonylphenoxy)-4-methylbenzoic acid

C17H16O8 (348.0845136)


   

2-hydroxy-6-(4-hydroxy-2-methoxy-6-methoxycarbonylphenoxy)-4-methylbenzoic acid

NCGC00180411-02!2-hydroxy-6-(4-hydroxy-2-methoxy-6-methoxycarbonylphenoxy)-4-methylbenzoic acid

C17H16O8 (348.0845136)


   

5-hydroxy-2-(3-hydroxy-2-methoxycarbonyl-5-methylphenoxy)-3-methoxybenzoic acid

NCGC00381013-01!5-hydroxy-2-(3-hydroxy-2-methoxycarbonyl-5-methylphenoxy)-3-methoxybenzoic acid

C17H16O8 (348.0845136)


   

Inosinic acid

Polyinosinic acid

C10H13N4O8P (348.0470988)


COVID info from clinicaltrial, clinicaltrials, clinical trial, clinical trials, COVID-19 Disease Map Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS Inosinic acid is an endogenous metabolite.

   

Inosine-5-monophosphate

Inosine-5-monophosphate

C10H13N4O8P (348.0470988)


   
   

2-hydroxy-6-(2-hydroxy-4-methoxy-6-methoxycarbonylphenoxy)-4-methylbenzoic acid [IIN-based: Match]

NCGC00384947-01!2-hydroxy-6-(2-hydroxy-4-methoxy-6-methoxycarbonylphenoxy)-4-methylbenzoic acid [IIN-based: Match]

C17H16O8 (348.0845136)


   

2-hydroxy-6-(2-hydroxy-4-methoxy-6-methoxycarbonylphenoxy)-4-methylbenzoic acid [IIN-based on: CCMSLIB00000847922]

NCGC00384947-01!2-hydroxy-6-(2-hydroxy-4-methoxy-6-methoxycarbonylphenoxy)-4-methylbenzoic acid [IIN-based on: CCMSLIB00000847922]

C17H16O8 (348.0845136)


   
   
   
   

asterric acid_major

asterric acid_major

C17H16O8 (348.0845136)


   

18-bromo-17E-octadecene

17-Octadecene-5,7,15-triynoic acid, 18-bromo-, (E)-

C18H21BrO2 (348.0724826)


   

2-IMP

Inosine 2-monophosphate

C10H13N4O8P (348.0470988)


   

18-bromo-17Z-octadecen-5,7,15-triynoic acid

18-bromo-17Z-octadecen-5,7,15-triynoic acid

C18H21BrO2 (348.0724826)


   

18-bromo-9E,15E,17E-octadecatrien-5,7-diynoic acid

18-bromo-9E,15E,17E-octadecatrien-5,7-diynoic acid

C18H21BrO2 (348.0724826)


   

Xestospongic acid

17-Octadecene-5,7,15-triynoic acid, 18-bromo-, (E)-

C18H21O2Br (348.0724826)


   

3,3-BIS(4-CHLOROBENZYL)-2,4-PENTANEDIONE

3,3-BIS(4-CHLOROBENZYL)-2,4-PENTANEDIONE

C19H18Cl2O2 (348.0683788)


   

Halocarban

Cloflucarban

C14H9Cl2F3N2O (348.0044)


C254 - Anti-Infective Agent > C28394 - Topical Anti-Infective Agent

   

1,1-Binaphthyl-2,2-diyl hydrogenphosphate

1,1-Binaphthyl-2,2-diyl hydrogenphosphate

C20H13O4P (348.05514280000006)


   

2-(4-Bromophenyl)-3-phenylimidazo[1,2-a]pyridine

2-(4-Bromophenyl)-3-phenylimidazo[1,2-a]pyridine

C19H13BrN2 (348.0262038)


   
   

2-(5-bromo-2-pyridylazo)-5-diethylaminophenol

2-(5-bromo-2-pyridylazo)-5-diethylaminophenol

C15H17BrN4O (348.0585652)


   

2-(4-Bromophenyl)-1-phenyl-1H-benzimidazole

2-(4-Bromophenyl)-1-phenyl-1H-benzimidazole

C19H13BrN2 (348.0262038)


   

2-(2-Fluoro-4-iodophenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane

2-(2-Fluoro-4-iodophenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane

C12H15BFIO2 (348.0193842)


   

1-(2-bromonaphthalen-1-yl)naphthalen-2-ol

1-(2-bromonaphthalen-1-yl)naphthalen-2-ol

C20H13BrO (348.0149708)


   

3-(trimethylsilyl)-2-naphthyl trifluoromethanesulfonate

3-(trimethylsilyl)-2-naphthyl trifluoromethanesulfonate

C14H15F3O3SSi (348.0463236)


   

alpha-(4-Methoxybenzoyl)-2-chloro-4-nitroacetanilide

alpha-(4-Methoxybenzoyl)-2-chloro-4-nitroacetanilide

C16H13ClN2O5 (348.05129580000005)


   

3-(Heptafluorobutyryl)-I-Camphor

3-(Heptafluorobutyryl)-I-Camphor

C14H15F7O2 (348.0960214)


   

Methanone,(7-bromo-2,3-dihydro-1,4-benzodioxin-6-yl)(2-methoxyphenyl)-

Methanone,(7-bromo-2,3-dihydro-1,4-benzodioxin-6-yl)(2-methoxyphenyl)-

C16H13BrO4 (347.99971580000005)


   

1,6-Dideoxy-1,1-bis(ethylsulfonyl)-L-mannitol

1,6-Dideoxy-1,1-bis(ethylsulfonyl)-L-mannitol

C11H24O8S2 (348.09125439999997)


   

1-(4-chloro-3-isocyanatobenzenesulfonyl)-1,2,3,4-tetrahydroquinoline

1-(4-chloro-3-isocyanatobenzenesulfonyl)-1,2,3,4-tetrahydroquinoline

C16H13ClN2O3S (348.0335378000001)


   

1-(trimethylsilyl)-2-naphthyl triflate

1-(trimethylsilyl)-2-naphthyl triflate

C14H15F3O3SSi (348.0463236)


   

1,3-DIAMINO-4-(HEPTAFLUOROISOPROPYL)BENZENE DIHYDROCHLORIDE

1,3-DIAMINO-4-(HEPTAFLUOROISOPROPYL)BENZENE DIHYDROCHLORIDE

C9H9Cl2F7N2 (348.00309780000003)


   

4,4-DIHYDROXYOCTAFLUORODIPHENYL MONOHYDRATE

4,4-DIHYDROXYOCTAFLUORODIPHENYL MONOHYDRATE

C12H4F8O3 (348.00326899999993)


   

2-methoxy-6-[(4-methylphenyl)sulfonyloxymethyl]oxane-3,4,5-triol

2-methoxy-6-[(4-methylphenyl)sulfonyloxymethyl]oxane-3,4,5-triol

C14H20O8S (348.08788400000003)


   

(R)-(-)-1,1-Binaphthyl-2,2-diyl hydrogenphosphate

(R)-(-)-1,1-Binaphthyl-2,2-diyl hydrogenphosphate

C20H13O4P (348.05514280000006)


   

2-BROMO-2,6-DIISOPROPOXY-1,1-BIPHENYL

2-BROMO-2,6-DIISOPROPOXY-1,1-BIPHENYL

C18H21BrO2 (348.0724826)


   

(S)-(+)-1,1-Binaphthyl-2,2-diyl hydrogenphosphate

(S)-(+)-1,1-Binaphthyl-2,2-diyl hydrogenphosphate

C20H13O4P (348.05514280000006)


   

Dioxopromethazine hydrochloride

Dioxopromethazine hydrochloride

C17H17ClN2O2S (348.0699212)


   

3-heptafluorobutyryl-(+)-camphor

3-heptafluorobutyryl-(+)-camphor

C14H15F7O2 (348.0960214)


   

N-(4-aminobutyl)-5-chloro-2-naphthalenesulfonamide hydrochloride

N-(4-aminobutyl)-5-chloro-2-naphthalenesulfonamide hydrochloride

C14H18Cl2N2O2S (348.0465988)


   

METHYL 4-(3-(4-(TRIFLUOROMETHYL)PHENYL)-1,2,4-OXADIAZOL-5-YL)BENZOATE

METHYL 4-(3-(4-(TRIFLUOROMETHYL)PHENYL)-1,2,4-OXADIAZOL-5-YL)BENZOATE

C17H11F3N2O3 (348.07217319999995)


   

2-(3-Bromophenyl)-1-phenyl-1H-benzimidazole

2-(3-Bromophenyl)-1-phenyl-1H-benzimidazole

C19H13BrN2 (348.0262038)


   
   

2-ETHOXY-5-[(MORPHOLINE-4-CARBONYL)-AMINO]-BENZENESULFONYL CHLORIDE

2-ETHOXY-5-[(MORPHOLINE-4-CARBONYL)-AMINO]-BENZENESULFONYL CHLORIDE

C13H17ClN2O5S (348.05466620000004)


   

4,6-Dichloro-5-(2-methoxyphenoxy)-2,2-bipyrimidine

4,6-Dichloro-5-(2-methoxyphenoxy)-2,2-bipyrimidine

C15H10Cl2N4O2 (348.018078)


   

1,2,3,4,5,6-Cyclohexanehexacarboxylic acid

1,2,3,4,5,6-Cyclohexanehexacarboxylic acid

C12H12O12 (348.03287520000003)


   

Pifithrin-β (hydrobromide)

Pifithrin-β (hydrobromide)

C16H17BrN2S (348.0295742)


Pifithrin-β hydrobromide (PFT β hydrobromide) is a potent p53 inhibitor with an IC50 of 23 μM.

   
   

1-(4-Bromophenyl)-2-phenyl-1H-benzimidazole

1-(4-Bromophenyl)-2-phenyl-1H-benzimidazole

C19H13BrN2 (348.0262038)


   

3-(5-Cyano-2-hydroxy-1,4-dimethyl-6-oxo-1,6-dihydropyridin-3-ylazo)benzenesulfonicacid

3-(5-Cyano-2-hydroxy-1,4-dimethyl-6-oxo-1,6-dihydropyridin-3-ylazo)benzenesulfonicacid

C14H12N4O5S (348.0528382)


   
   

2-(N-Boc-methylamino)-5-iodo-3-methylpyridine

2-(N-Boc-methylamino)-5-iodo-3-methylpyridine

C12H17IN2O2 (348.0334732)


   

Ethyl 4-(3-bromo-4-formylphenoxy)benzoate

Ethyl 4-(3-bromo-4-formylphenoxy)benzoate

C16H13BrO4 (347.99971580000005)


   

1-Naphthalenamine,2,2-dithiobis-

1-Naphthalenamine,2,2-dithiobis-

C20H16N2S2 (348.0754856)


   

2,2,3,3,4,4-hexafluoro-1,5-pentyl dimethacrylate

2,2,3,3,4,4-hexafluoro-1,5-pentyl dimethacrylate

C13H14F6O4 (348.07962360000005)


   

5-(4-chlorophenyl)-N-quinolin-6-ylfuran-2-carboxamide

5-(4-chlorophenyl)-N-quinolin-6-ylfuran-2-carboxamide

C20H13ClN2O2 (348.0665508)


   
   

n-epsilon-2,4-dnp-l-lysine hydrochloride

n-epsilon-2,4-dnp-l-lysine hydrochloride

C12H17ClN4O6 (348.0836572)


   

2,4-Dinitrophenyl 2-Deoxy-2-Fluoro-Beta-D-Glucopyranoside

2,4-Dinitrophenyl 2-Deoxy-2-Fluoro-Beta-D-Glucopyranoside

C12H13FN2O9 (348.06050600000003)


   

4-AMINO-N-(3,5-BIS(TRIFLUOROMETHYL)PHENYL)BENZAMIDE

4-AMINO-N-(3,5-BIS(TRIFLUOROMETHYL)PHENYL)BENZAMIDE

C15H10F6N2O (348.0697282)


   

10-(4-methylphenyl)-7-nitropyrimido[4,5-b]quinoline-2,4-dione

10-(4-methylphenyl)-7-nitropyrimido[4,5-b]quinoline-2,4-dione

C18H12N4O4 (348.08585120000004)


   

(4-nitrophenyl)methyl 6-(1-hydroxyethyl)-3,7-dioxo-1-azabicyclo[3.2.0]heptane-2-carboxylate

(4-nitrophenyl)methyl 6-(1-hydroxyethyl)-3,7-dioxo-1-azabicyclo[3.2.0]heptane-2-carboxylate

C16H16N2O7 (348.0957466)


   

N-([3,5-BIS(TRIFLUOROMETHYL)BENZOYL]OXY)-2-CHLOROETHANIMIDAMIDE

N-([3,5-BIS(TRIFLUOROMETHYL)BENZOYL]OXY)-2-CHLOROETHANIMIDAMIDE

C11H7ClF6N2O2 (348.01002239999997)


   

Thallium(I) 2-ethylhexanoate

Thallium(I) 2-ethylhexanoate

C8H15O2Tl (348.081609)


   

N-(3-chloro-4-fluorophenyl)-7-methoxy-6-nitroquinazolin-4-amine

N-(3-chloro-4-fluorophenyl)-7-methoxy-6-nitroquinazolin-4-amine

C15H10ClFN4O3 (348.04254319999995)


   
   

4-Oxo-2-phenyl-4H-chromen-3-yl 2-thiophenecarboxylate

4-Oxo-2-phenyl-4H-chromen-3-yl 2-thiophenecarboxylate

C20H12O4S (348.0456272)


   

6-(Trifluoromethyl)-2-pyridinemethanol 2-(4-methylbenzenesulfonate)

6-(Trifluoromethyl)-2-pyridinemethanol 2-(4-methylbenzenesulfonate)

C14H13F3NO4S (348.05173540000004)


   

3-(heptafluoroisopropoxy)propyltrimethoxysilane

3-(heptafluoroisopropoxy)propyltrimethoxysilane

C9H15F7O4Si (348.0627794)


   
   

1-​Piperazineethanol, 4-​[(3-​bromophenyl)​sulfonyl]​-

1-​Piperazineethanol, 4-​[(3-​bromophenyl)​sulfonyl]​-

C12H17BrN2O3S (348.01431920000005)


   
   

3-(perfluorobutyl)-2-hydroxypropyl acrylate

3-(perfluorobutyl)-2-hydroxypropyl acrylate

C10H9F9O3 (348.04079519999993)


   

(Acetylacetonato)dicarbonyliridium (I)

(Acetylacetonato)dicarbonyliridium (I)

C7H7IrO4 (347.9973742)


   

Diethyl2,6-bis(methylthio)-4-oxo-4H-thiopyran-3,5-dicarboxylate

Diethyl2,6-bis(methylthio)-4-oxo-4H-thiopyran-3,5-dicarboxylate

C13H16O5S3 (348.0159846)


   

1-Bromo-6-ferrocenylhexane 6-Ferrocenylhexyl bromide

1-Bromo-6-ferrocenylhexane 6-Ferrocenylhexyl bromide

C16H21BrFe (348.0175916)


   
   
   
   

(4R)-2-(2,3-dihydroxyphenyl)-N-hydroxy-N-[2-(1H-imidazol-5-yl)ethyl]-4,5-dihydro-1,3-thiazole-4-carboxamide

(4R)-2-(2,3-dihydroxyphenyl)-N-hydroxy-N-[2-(1H-imidazol-5-yl)ethyl]-4,5-dihydro-1,3-thiazole-4-carboxamide

C15H16N4O4S (348.08922160000003)


D064449 - Sequestering Agents > D002614 - Chelating Agents > D007502 - Iron Chelating Agents

   

4-hydroxy-2-oxo-N-[3-(trifluoromethyl)phenyl]-1,2-dihydroquinoline-3-carboxamide

4-hydroxy-2-oxo-N-[3-(trifluoromethyl)phenyl]-1,2-dihydroquinoline-3-carboxamide

C17H11F3N2O3 (348.07217319999995)


   

Lactucin 15-oxalate

Lactucin 15-oxalate

C17H16O8 (348.0845136)


A sesquiterpene lactone obtained by formal condensation of one of the carboxy groups of oxalic acid with the 15-hydroxy group of lactucin. Found in chicory.

   

5-[(6-Methoxy-1,3-benzothiazol-2-yl)amino]-3-methyl-2-thiophenecarboxylic acid ethyl ester

5-[(6-Methoxy-1,3-benzothiazol-2-yl)amino]-3-methyl-2-thiophenecarboxylic acid ethyl ester

C16H16N2O3S2 (348.0602306)


   

3-(2-Chlorophenyl)-7-hydroxy-4-phenylchromen-2-one

3-(2-Chlorophenyl)-7-hydroxy-4-phenylchromen-2-one

C21H13ClO3 (348.0553178)


   

(5z)-3-(4-Chlorophenyl)-4-Hydroxy-5-(1-Naphthylmethylene)furan-2(5h)-One

(5z)-3-(4-Chlorophenyl)-4-Hydroxy-5-(1-Naphthylmethylene)furan-2(5h)-One

C21H13ClO3 (348.0553178)


   

2,4-Dinitrophenyl 2-Deoxy-2-Fluoro-Beta-D-Mannopyranoside

2,4-Dinitrophenyl 2-Deoxy-2-Fluoro-Beta-D-Mannopyranoside

C12H13FN2O9 (348.06050600000003)


   

N7-(5-Phospho-alpha-ribosyl)-2-hydroxypurine

N7-(5-Phospho-alpha-ribosyl)-2-hydroxypurine

C10H13N4O8P (348.0470988)


   

{[4-Amino-2-(3-chloroanilino)-1,3-thiazol-5-YL](4-fluorophenyl)methanone

{[4-Amino-2-(3-chloroanilino)-1,3-thiazol-5-YL](4-fluorophenyl)methanone

C16H12ClFN3OS+ (348.0373604)


   

Tolestan

cloxazolam

C17H14Cl2N2O2 (348.0432284)


N - Nervous system > N05 - Psycholeptics > N05B - Anxiolytics > N05BA - Benzodiazepine derivatives C78272 - Agent Affecting Nervous System > C28197 - Antianxiety Agent

   

5-Hydroxy-2-(3-hydroxy-2-methoxycarbonyl-5-methylphenoxy)-3-methoxybenzoic acid

5-Hydroxy-2-(3-hydroxy-2-methoxycarbonyl-5-methylphenoxy)-3-methoxybenzoic acid

C17H16O8 (348.0845136)


   

2-Hydroxy-6-(2-hydroxy-4-methoxy-6-methoxycarbonylphenoxy)-4-methylbenzoic acid

2-Hydroxy-6-(2-hydroxy-4-methoxy-6-methoxycarbonylphenoxy)-4-methylbenzoic acid

C17H16O8 (348.0845136)


D065128 - Endothelin Receptor Antagonists

   
   

2,4-DINITROPHENYL-2-FLUORO-2-DEOXY-BETA-D-GLUCOPYRANOSIDE

2,4-DINITROPHENYL-2-FLUORO-2-DEOXY-BETA-D-GLUCOPYRANOSIDE

C12H13FN2O9 (348.06050600000003)


   

3-deoxy-D-glycero-beta-D-galacto-nonulosonic acid 9-phosphate

3-deoxy-D-glycero-beta-D-galacto-nonulosonic acid 9-phosphate

C9H17O12P (348.0457612)


A ketoaldonic acid phosphate that is 3-deoxy-D-glycero-beta-D-galacto-nonulosonic acid carrying a monophosohate substituent at position 9.

   
   

Nomega-phospho-D-lombricine

Nomega-phospho-D-lombricine

C6H14N4O9P2-2 (348.0236014)


   

[5-(2,6-dioxo-3H-purin-9-yl)-3-hydroxyoxolan-2-yl]methyl dihydrogen phosphate

[5-(2,6-dioxo-3H-purin-9-yl)-3-hydroxyoxolan-2-yl]methyl dihydrogen phosphate

C10H13N4O8P (348.0470988)


   

(2S)-5-[[(2R)-3-acetylsulfanyl-1-(carboxylatomethylamino)-1-oxopropan-2-yl]amino]-2-azaniumyl-5-oxopentanoate

(2S)-5-[[(2R)-3-acetylsulfanyl-1-(carboxylatomethylamino)-1-oxopropan-2-yl]amino]-2-azaniumyl-5-oxopentanoate

C12H18N3O7S- (348.0865418)


   

(2R)-3-phosphonooxy-2-[(2R,3S,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxypropanoic acid

(2R)-3-phosphonooxy-2-[(2R,3S,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxypropanoic acid

C9H17O12P (348.0457612)


   
   

[2,3,4,5-Tetrahydroxy-6-(phosphonooxymethyl)oxan-2-yl] 2-hydroxypropanoate

[2,3,4,5-Tetrahydroxy-6-(phosphonooxymethyl)oxan-2-yl] 2-hydroxypropanoate

C9H17O12P (348.0457612)


   

8-Demethylthymonin

8-Demethylthymonin

C17H16O8 (348.0845136)


   

Formononetin 7-sulfate

Formononetin 7-sulfate

C16H12O7S (348.0303722)


   

Aflatoxin B1 dialdehyde

Aflatoxin B1 dialdehyde

C16H12O9 (348.0481302)


   

4-Chloro-6-[5-(4-ethoxyphenyl)-1,2,3-thiadiazol-4-yl]benzene-1,3-diol

4-Chloro-6-[5-(4-ethoxyphenyl)-1,2,3-thiadiazol-4-yl]benzene-1,3-diol

C16H13ClN2O3S (348.0335378000001)


   

N-(bicyclo[2.2.1]hept-2-ylcarbonyl)-3-chloro-1-benzothiophene-2-carbohydrazide

N-(bicyclo[2.2.1]hept-2-ylcarbonyl)-3-chloro-1-benzothiophene-2-carbohydrazide

C17H17ClN2O2S (348.0699212)


   

5-[(3-chlorophenoxy)methyl]-N-(4-methyl-2-thiazolyl)-2-furancarboxamide

5-[(3-chlorophenoxy)methyl]-N-(4-methyl-2-thiazolyl)-2-furancarboxamide

C16H13ClN2O3S (348.0335378000001)


   

4-Chloro-3-[[(2-methyl-3-nitrophenyl)-oxomethyl]amino]benzoic acid methyl ester

4-Chloro-3-[[(2-methyl-3-nitrophenyl)-oxomethyl]amino]benzoic acid methyl ester

C16H13ClN2O5 (348.05129580000005)


   

(2-Methyl-3-imidazo[1,2-a]pyridinyl)-diphenyl-sulfanylidenephosphorane

(2-Methyl-3-imidazo[1,2-a]pyridinyl)-diphenyl-sulfanylidenephosphorane

C20H17N2PS (348.0850012)


   

({6-[4-(Methylsulfanyl)phenyl]thieno[3,2-d]pyrimidin-4-yl}sulfanyl)acetic acid

({6-[4-(Methylsulfanyl)phenyl]thieno[3,2-d]pyrimidin-4-yl}sulfanyl)acetic acid

C15H12N2O2S3 (348.0060892)


   

N1-Protonated adenosine-5-monophosphate

N1-Protonated adenosine-5-monophosphate

C10H15N5O7P+ (348.07090700000003)


COVID info from COVID-19 Disease Map Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS

   

3-(4-Bromoanilino)-1-(3-nitrophenyl)-1-propanone

3-(4-Bromoanilino)-1-(3-nitrophenyl)-1-propanone

C15H13BrN2O3 (348.01094880000005)


   

N-(1,3-dioxo-2-phenyl-5-isoindolyl)-2-thiophenecarboxamide

N-(1,3-dioxo-2-phenyl-5-isoindolyl)-2-thiophenecarboxamide

C19H12N2O3S (348.0568602000001)


   

N-[3-(5-methyl-1,3-benzoxazol-2-yl)phenyl]-2-thiophen-2-ylacetamide

N-[3-(5-methyl-1,3-benzoxazol-2-yl)phenyl]-2-thiophen-2-ylacetamide

C20H16N2O2S (348.0932436)


   

Loracarbef anion

Loracarbef anion

C16H15ClN3O4- (348.075104)


The conjugate base of loracarbef.

   

Inosine 3-monophosphate

Inosine 3-monophosphate

C10H13N4O8P (348.0470988)


   

N-phosphonato-L-lombricine(2-)

N-phosphonato-L-lombricine(2-)

C6H14N4O9P2-2 (348.0236014)


   

4-chloro-3-nitrobenzaldehyde N-(4-methylphenyl)thiosemicarbazone

4-chloro-3-nitrobenzaldehyde N-(4-methylphenyl)thiosemicarbazone

C15H13ClN4O2S (348.04477080000004)


   

4-[(2-oxo-3H-1,3-benzoxazol-6-yl)sulfonylamino]benzoic acid methyl ester

4-[(2-oxo-3H-1,3-benzoxazol-6-yl)sulfonylamino]benzoic acid methyl ester

C15H12N2O6S (348.04160520000005)


   

2-Benzamido-4,5-dihydrobenzo[g][1]benzothiole-3-carboxamide

2-Benzamido-4,5-dihydrobenzo[g][1]benzothiole-3-carboxamide

C20H16N2O2S (348.0932436)


   

3-(2-chloro-6-fluorophenyl)-N-(2-hydroxy-5-methylphenyl)-4,5-dihydroisoxazole-5-carboxamide

3-(2-chloro-6-fluorophenyl)-N-(2-hydroxy-5-methylphenyl)-4,5-dihydroisoxazole-5-carboxamide

C17H14ClFN2O3 (348.0676936)


   

N-[4-(4-fluorophenyl)-2-thiazolyl]-4-methylbenzenesulfonamide

N-[4-(4-fluorophenyl)-2-thiazolyl]-4-methylbenzenesulfonamide

C16H13FN2O2S2 (348.04024499999997)


   

6-Propyl-2-[(2-thienylcarbonyl)amino]-4,5,6,7-tetrahydro-1-benzothiophene-3-carboxamide

6-Propyl-2-[(2-thienylcarbonyl)amino]-4,5,6,7-tetrahydro-1-benzothiophene-3-carboxamide

C17H20N2O2S2 (348.096614)


   

N-[1-[(2-bromophenyl)methyl]-2-oxo-3-pyridinyl]butanamide

N-[1-[(2-bromophenyl)methyl]-2-oxo-3-pyridinyl]butanamide

C16H17BrN2O2 (348.04733219999997)


   

N-[3-[(1,3-dioxo-5-isoindolyl)oxy]phenyl]-2-furancarboxamide

N-[3-[(1,3-dioxo-5-isoindolyl)oxy]phenyl]-2-furancarboxamide

C19H12N2O5 (348.07461820000003)


   

2-[(5-amino-7-methyl-[1,2,4]triazolo[4,3-c]pyrimidin-3-yl)thio]-N-(4-chlorophenyl)acetamide

2-[(5-amino-7-methyl-[1,2,4]triazolo[4,3-c]pyrimidin-3-yl)thio]-N-(4-chlorophenyl)acetamide

C14H13ClN6OS (348.05600380000004)


   

(3E)-N-(3,5-dichloroanilino)-6,7,8,9-tetrahydro-5H-[1,2,4]triazolo[4,3-a]azepine-3-carboximidoyl cyanide

(3E)-N-(3,5-dichloroanilino)-6,7,8,9-tetrahydro-5H-[1,2,4]triazolo[4,3-a]azepine-3-carboximidoyl cyanide

C15H14Cl2N6 (348.0656944)


   

2-(alpha-D-mannosyl)-3-phosphoglyceric acid

2-(alpha-D-mannosyl)-3-phosphoglyceric acid

C9H17O12P (348.0457612)


   

N-[(2S,3R,6R)-6-(2-aminoethyl)-2-(hydroxymethyl)-3-oxanyl]-4-chlorobenzenesulfonamide

N-[(2S,3R,6R)-6-(2-aminoethyl)-2-(hydroxymethyl)-3-oxanyl]-4-chlorobenzenesulfonamide

C14H21ClN2O4S (348.0910496)


   

N-[(2R,3R,6S)-6-(2-aminoethyl)-2-(hydroxymethyl)-3-oxanyl]-4-chlorobenzenesulfonamide

N-[(2R,3R,6S)-6-(2-aminoethyl)-2-(hydroxymethyl)-3-oxanyl]-4-chlorobenzenesulfonamide

C14H21ClN2O4S (348.0910496)


   

N-[(2S,3R,6S)-6-(2-aminoethyl)-2-(hydroxymethyl)-3-oxanyl]-4-chlorobenzenesulfonamide

N-[(2S,3R,6S)-6-(2-aminoethyl)-2-(hydroxymethyl)-3-oxanyl]-4-chlorobenzenesulfonamide

C14H21ClN2O4S (348.0910496)


   

N-[(2R,3S,6R)-6-(2-aminoethyl)-2-(hydroxymethyl)-3-oxanyl]-4-chlorobenzenesulfonamide

N-[(2R,3S,6R)-6-(2-aminoethyl)-2-(hydroxymethyl)-3-oxanyl]-4-chlorobenzenesulfonamide

C14H21ClN2O4S (348.0910496)


   

N-[(2R,3R,6R)-6-(2-aminoethyl)-2-(hydroxymethyl)-3-oxanyl]-4-chlorobenzenesulfonamide

N-[(2R,3R,6R)-6-(2-aminoethyl)-2-(hydroxymethyl)-3-oxanyl]-4-chlorobenzenesulfonamide

C14H21ClN2O4S (348.0910496)


   

N-[(2R,3S,6S)-6-(2-aminoethyl)-2-(hydroxymethyl)-3-oxanyl]-4-chlorobenzenesulfonamide

N-[(2R,3S,6S)-6-(2-aminoethyl)-2-(hydroxymethyl)-3-oxanyl]-4-chlorobenzenesulfonamide

C14H21ClN2O4S (348.0910496)


   

N-[(2S,3S,6R)-6-(2-aminoethyl)-2-(hydroxymethyl)-3-oxanyl]-4-chlorobenzenesulfonamide

N-[(2S,3S,6R)-6-(2-aminoethyl)-2-(hydroxymethyl)-3-oxanyl]-4-chlorobenzenesulfonamide

C14H21ClN2O4S (348.0910496)


   

5,7-Dihydroxy-2-(1-hydroxy-3,5-dimethoxy-4-oxocyclohex-2-en-1-yl)chromen-4-one

5,7-Dihydroxy-2-(1-hydroxy-3,5-dimethoxy-4-oxocyclohex-2-en-1-yl)chromen-4-one

C17H16O8 (348.0845136)


   

2-(2,5-Dihydroxy-4-methoxyphenyl)-3,5,6,7-tetrahydroxychromen-4-one

2-(2,5-Dihydroxy-4-methoxyphenyl)-3,5,6,7-tetrahydroxychromen-4-one

C16H12O9 (348.0481302)


   

7-chloro-5-(2-chlorophenyl)-3-methoxy-1-methyl-1,3-dihydro-2H-1,4-benzodiazepin-2-one

7-chloro-5-(2-chlorophenyl)-3-methoxy-1-methyl-1,3-dihydro-2H-1,4-benzodiazepin-2-one

C17H14Cl2N2O2 (348.0432284)


   
   

alpha-(1,2-Dihydroxyethyl)-1,2,3,4-tetrahydro-7-hydroxy-9-methoxy-3,4-dioxocyclopenta[c][1]benzopyran-6-acetaldehyde

alpha-(1,2-Dihydroxyethyl)-1,2,3,4-tetrahydro-7-hydroxy-9-methoxy-3,4-dioxocyclopenta[c][1]benzopyran-6-acetaldehyde

C17H16O8 (348.0845136)


   

2-O-(6-Phospho-alpha-mannosyl)-D-glycerate

2-O-(6-Phospho-alpha-D-mannosyl)-D-glycerate

C9H17O12P (348.0457612)


   

adenosine 5-monophosphate(1+)

adenosine 5-monophosphate(1+)

C10H15N5O7P (348.07090700000003)


An organic cation that is the conjugate acid of adenosine 5-monophosphate (AMP) obtained by selective protonation at position N1 on the purine moiety.

   

18-bromo-17E-octadecen-5,7,15-triynoic acid

18-bromo-17E-octadecen-5,7,15-triynoic acid

C18H21BrO2 (348.0724826)


   

IMP

IMP

C10H13N4O8P (348.0470988)


A purine ribonucleoside 5-monophosphate having hypoxanthine as the nucleobase.

   

BPR1M97

BPR1M97

C18H18Cl2N2O (348.0796118)


BPR1M97 is a dual-acting mu opioid receptor (MOP) and nociceptin-orphanin FQ peptide (NOP) receptor agonist with Ki values of 1.8 and 4.2 nM, respectively. BPR1M97 shows high potency and blood-brain barrier penetration, and produces potent antinociceptive effects[1].